| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan 52900, Israel
p94fer and p51ferT are two tyrosine kinases that are encoded by differentially spliced transcripts of the FER locus in the mouse. The two tyrosine kinases share identical SH2 and kinase domains but differ in their NH2-terminal amino acid sequence. Unlike p94fer, the presence of which has been demonstrated in most mammalian cell lines analyzed, the expression of p51ferT is restricted to meiotic cells. Here, we show that the two related tyrosine kinases also differ in their subcellular localization profiles. Although p51ferT accumulates constitutively in the cell nucleus, p94fer is cytoplasmic in quiescent cells and enters the nucleus concomitantly with the onset of S phase.
The nuclear translocation of the FER proteins is driven by a nuclear localization signal (NLS), which is located within the kinase domain of these enzymes. The functioning of that NLS depends on the integrity of the kinase domain but was not affected by inactivation of the kinase activity. The NH2 terminus of p94fer dictated the cell cycle-dependent functioning of the NLS of FER kinase. This process was governed by coiled-coil forming sequences that are present in the NH2 terminus of the kinase. The regulatory effect of the p94fer NH2-terminal sequences was not affected by kinase activity but was perturbed by mutations in the kinase domain ATP binding site.
Ectopic expression of the constitutively nuclear p51ferT in CHO cells interfered with S-phase progression in these cells. This was not seen in p94fer-overexpressing cells. The FER tyrosine kinases seem, thus, to be regulated by novel mechanisms that direct their different subcellular distribution profiles and may, consequently, control their cellular functioning.
This article has been cited by other articles:
![]() |
A. Zoubeidi, J. Rocha, F. Z. Zouanat, L. Hamel, E. Scarlata, A. G. Aprikian, and S. Chevalier The Fer Tyrosine Kinase Cooperates with Interleukin-6 to Activate Signal Transducer and Activator of Transcription 3 and Promote Human Prostate Cancer Cell Growth Mol. Cancer Res., January 1, 2009; 7(1): 142 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Y. E. Sayegh, P. D. Arora, L. Fan, C. A. Laschinger, P. A. Greer, C. A. McCulloch, and A. Kapus Phosphorylation of N-Cadherin-associated Cortactin by Fer Kinase Regulates N-Cadherin Mobility and Intercellular Adhesion Strength Mol. Biol. Cell, December 1, 2005; 16(12): 5514 - 5527. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Putzke, S. T. Hikita, D. O. Clegg, and J. H. Rothman Essential kinase-independent role of a Fer-like non-receptor tyrosine kinase in Caenorhabditis elegans morphogenesis Development, July 15, 2005; 132(14): 3185 - 3195. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kogata, M. Masuda, Y. Kamioka, A. Yamagishi, A. Endo, M. Okada, and N. Mochizuki Identification of Fer Tyrosine Kinase Localized on Microtubules as a Platelet Endothelial Cell Adhesion Molecule-1 Phosphorylating Kinase in Vascular Endothelial Cells Mol. Biol. Cell, September 1, 2003; 14(9): 3553 - 3564. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Taler, S. Shpungin, Y. Salem, H. Malovani, O. Pasder, and U. Nir Fer Is a Downstream Effector of Insulin and Mediates the Activation of Signal Transducer and Activator of Transcription 3 in Myogenic Cells Mol. Endocrinol., August 1, 2003; 17(8): 1580 - 1592. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. B. Craig and P. A. Greer Fer Kinase Is Required for Sustained p38 Kinase Activation and Maximal Chemotaxis of Activated Mast Cells Mol. Cell. Biol., September 15, 2002; 22(18): 6363 - 6374. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-M. McCafferty, A. W. B. Craig, Y. A. Senis, and P. A. Greer Absence of Fer Protein-Tyrosine Kinase Exacerbates Leukocyte Recruitment in Response to Endotoxin J. Immunol., May 15, 2002; 168(10): 4930 - 4935. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Priel-Halachmi, I. Ben-Dor, S. Shpungin, T. Tennenbaum, H. Molavani, M. Bachrach, S. Salzberg, and U. Nir FER Kinase Activation of Stat3 Is Determined by the N-terminal Sequence J. Biol. Chem., September 8, 2000; 275(37): 28902 - 28910. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |